This company seems to have been delisted
Reason: Acquired by Neuphoria Therapeutics
Last recorded trade on: February 25, 2025
Source: https://www.nasdaq.com/articles/neuphoria-therapeutics-inc-completes-scheme-arrangement-bionomics-limiteds-re
Reason: Acquired by Neuphoria Therapeutics
Last recorded trade on: February 25, 2025
Source: https://www.nasdaq.com/articles/neuphoria-therapeutics-inc-completes-scheme-arrangement-bionomics-limiteds-re
Bionomics
BNOX
0,22 €
Share price
4.59%
Change (1 day)
-76.60%
Change (1 year)
Categories
Revenue for Bionomics (BNOX)
Revenue in 2024 (TTM): €0.63 Million
According to Bionomics's latest financial reports the company's current revenue (TTM 
) is €0.58 Million. In 2023 the company made a revenue of €0.01 Million a decrease over the revenue in the year 2022 that were of €0.23 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Bionomics from 2001 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | €0.63 M | 4852.48% |
| 2023 | €0.01 M | -94.46% |
| 2022 | €0.23 M | |
| 2021 | N/A | -100% |
| 2020 | €0.02 M | -98.81% |
| 2019 | €2.36 M | -3.35% |
| 2018 | €2.44 M | -32.74% |
| 2017 | €3.64 M | -20.8% |
| 2016 | €4.59 M | 2.56% |
| 2015 | €4.48 M | -71.78% |
| 2014 | €15.88 M | 1104.64% |
| 2013 | €1.31 M | 29.74% |
| 2012 | €1.01 M | -66.11% |
| 2011 | €2.99 M | 35.15% |
| 2010 | €2.21 M | -13.48% |
| 2009 | €2.56 M | 169.83% |
| 2008 | €0.95 M | 55.88% |
| 2007 | €0.6 M | 42.82% |
| 2006 | €0.42 M | 114.87% |
| 2005 | €0.19 M | |
| 2004 | N/A | -100% |
| 2003 | €0.6 M | -24.09% |
| 2002 | €0.79 M | 195.12% |
| 2001 | €0.27 M |